Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Early Phase CRO Services

A Strong Start Toward a Healthier World

Pharm-Olam Pharm-Olam

Pharm-Olam has more than 25 years of experience in early-stage research. We understand the importance of your early decisions in setting up your trial and how those choices impact study success. As your partner, we deploy our network of seasoned, early-phase investigators to maximize your Phase 1 clinical trial for success.

From project management to data management and from site feasibility to pharmacokinetics, our experts are ready to help you work through the specific challenges posed by early-stage research. Our attention to detail helps ensure that your studies start fast and that you have the information you need to make those critical decisions and reassure all your stakeholders. With a global presence in more than 60 countries, we can identify appropriate sites wherever your study takes you.



Our deep expertise in Phase 1 research includes:

First-in-human trials
Single ascending dose (SAD), multiple ascending dose (MAD)
Natural studies
Human absorption, metabolism, and excretion (AME)
Special procedures
Health normal volunteers
Pharm-Olam Pharm-Olam

Full-Service Capabilities to Support Early Phase Research

Your study is unique, which is why we offer a complete suite of customizable services to support your research in a full-service or functional provider setting. With Pharm-Olam as your partner, you can be assured you will have the support you need for your study’s unique requirements. We have strong working relationships with Phase I investigators and units around the globe, and we are committed to ensuring high-quality data and adherence to all good clinical practices and regulations.

Our services include:

Pharm-Olam Pharm-Olam
Pharm-Olam Pharm-Olam

Put Our Therapeutic Experts to Work on Your Challenges

Pharm-Olam has strategically invested in our therapeutic areas to provide aligned and experienced teams, sites, and supporting vendors; all of which are optimized to deliver your study effectively and on time. You can expect true expertise and innovative strategies from our team. We focus on the following areas:

  • Rare Disease– A recognized leader in rare disease research: We’ve conducted more than 100 rare disease studies and bring unique solutions to their unique challenges.
  • Infectious Disease & Vaccines – Our track record in this therapeutic area is a long one: We have supported the development of more than half of all antibiotics approved by FDA/EMA since 2010, and have strong and current experience in various emerging and re-emerging infectious diseases.
  • Oncology & Hematology– Deep experience in a variety of solid tumors and hematologic cancers with specific enhancements built to optimize early phase studies. 
  • AllergyThis therapeutic area presents a variety of unique challenges, such as seasonality and monotherapy, that our Allergy CRO team is well-equipped to handle.
  • Autoimmune - We have the expertise, investigator relationships, and supportive technology to effectively deliver autoimmune clinical research studies.
Pharm-Olam Pharm-Olam

Sponsor Testimonial

Pharm-Olam provided a predictable, high quality service that has not been matched by any other CRO we have worked with.”

Senior Vice President of Clinical Development and Medical Affairs.


Ready to take your formulation into a first in human study?

Our staff have the expertise to assist you.  Talk with our team today.